{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:51:07Z","timestamp":1773017467296,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12105-020-01130-6","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T07:02:37Z","timestamp":1580108557000},"page":"1117-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9878-1754","authenticated-orcid":false,"given":"Gon\u00e7alo","family":"Esteves","sequence":"first","affiliation":[]},{"given":"Joana","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Carmo","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Zagalo","sequence":"additional","affiliation":[]},{"given":"Ana","family":"F\u00e9lix","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"issue":"3","key":"1130_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","volume":"275","author":"P Giridhar","year":"2018","unstructured":"Giridhar P, Mallick S, Kashyap L, et al. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol. 2018;275(3):815\u201321.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"20","key":"1130_CR2","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","volume":"18","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18(20):5773\u20139.","journal-title":"Clin Cancer Res"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jcp.2007.052902","volume":"63","author":"CA French","year":"2008","unstructured":"French CA. Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol. 2008;63:492\u20136.","journal-title":"J Clin Pathol"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","volume":"22","author":"CA French","year":"2004","unstructured":"French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22:4135\u20139.","journal-title":"J Clin Oncol"},{"key":"1130_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00246-015-1313-3","volume":"37","author":"S Samples","year":"2016","unstructured":"Samples S, Gleditsch K, Polimenakos A. Intrapericardial NUT midline carcinoma: unusual presentation of a rare tumor and literature review with management considerations. Pediatr Cardiol. 2016;37:208\u201311.","journal-title":"Pediatr Cardiol"},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2350\/09-10-0727-CR.1","volume":"13","author":"BM Shehata","year":"2010","unstructured":"Shehata BM, Steelman CK, Abranowsky CR, et al. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic\/hepatic primary. Pediatr Dev Pathol. 2010;13:481\u20135.","journal-title":"Pediatr Dev Pathol"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/PAS.0b013e3181abe120","volume":"33","author":"MA Den Bakker","year":"2009","unstructured":"Den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol. 2009;33:1253\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1130_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12105-010-0174-6","volume":"4","author":"J Ziai","year":"2010","unstructured":"Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly differentiated carcinoma of the submandibular gland. Head Neck Pathol. 2010;4:163\u20138.","journal-title":"Head Neck Pathol"},{"key":"1130_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4132\/KoreanJPathol.2014.48.4.335","volume":"48","author":"HS Park","year":"2014","unstructured":"Park HS, Bae YS, Yoon SO, et al. Usefulness of nuclear protein in testis (NUT) immunohistochemistry in the cytodiagnosis of NUT midline carcinoma: a brief case report. Korean J Pathol. 2014;48:335\u20138.","journal-title":"Korean J Pathol"},{"key":"1130_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/dc.23506","volume":"44","author":"J Klijanienko","year":"2016","unstructured":"Klijanienko J, Le Tourneau C, Rodriguez J, et al. Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: report of two new cases and review of the literature. Diagn Cytopathol. 2016;44:753\u20136.","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"1130_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1179\/1973947815Y.0000000046","volume":"28","author":"C Vulsteke","year":"2016","unstructured":"Vulsteke C, Lurquin E, Debiec-Rychter M, et al. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4\/NUT translocation. J Chemother. 2016;28(3):242\u20136.","journal-title":"J Chemother"},{"issue":"3","key":"1130_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12105-015-0672-7","volume":"10","author":"S Andreasen","year":"2016","unstructured":"Andreasen S, French CA, Josiassen M, et al. NUT carcinoma of the sublingual gland. Head Neck Pathol. 2016;10(3):362\u20136.","journal-title":"Head Neck Pathol"},{"issue":"4","key":"1130_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12105-017-0809-y","volume":"11","author":"NB Seim","year":"2017","unstructured":"Seim NB, Philips RHW, Schoenfield L, et al. NUT midline carcinoma of the sublingual gland: clinical presentation and review. Head Neck Pathol. 2017;11(4):460\u20138.","journal-title":"Head Neck Pathol"},{"issue":"7","key":"1130_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/PAS.0000000000001046","volume":"42","author":"A Agaimy","year":"2018","unstructured":"Agaimy A, Fonseca I, Martins C, et al. NUT carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas. Am J Surg Pathol. 2018;42(7):877\u201384.","journal-title":"Am J Surg Pathol"},{"key":"1130_CR15","first-page":"304","volume":"63","author":"CA French","year":"2003","unstructured":"French CA, Miyoshi I, Kubonishi I, et al. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63:304\u20137.","journal-title":"Cancer Res"},{"issue":"6","key":"1130_CR16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0002-9440(10)63049-0","volume":"159","author":"CA French","year":"2001","unstructured":"French CA, Miyoshi I, Aster JC, et al. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol. 2001;159(6):1987\u201392.","journal-title":"Am J Pathol"},{"key":"1130_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2407-6-69","volume":"6","author":"J Engleson","year":"2006","unstructured":"Engleson J, Soller M, Panagopoulos I, et al. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. BMC Cancer. 2006;6:69.","journal-title":"BMC Cancer"},{"key":"1130_CR18","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984\u201391.","journal-title":"Am J Surg Pathol"},{"key":"1130_CR19","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-10-3513","volume":"71","author":"BE Schwartz","year":"2011","unstructured":"Schwartz BE, Hofer MD, Lemieux ME, et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 2011;71:2686\u201396.","journal-title":"Cancer Res"},{"key":"1130_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/pbc.20755","volume":"49","author":"F Mertens","year":"2007","unstructured":"Mertens F, Wiebe T, Adlercreutz C, et al. Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer. 2007;49:1015\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"1130_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/pbc.25350","volume":"62","author":"OM Maher","year":"2015","unstructured":"Maher OM, Christensen AM, Yedururi S, et al. Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer. 2015;62:715\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"1130_CR22","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","volume":"27","author":"CA French","year":"2008","unstructured":"French CA, Ramirez CL, Kolmakova J, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27:2237\u201342.","journal-title":"Oncogene"},{"issue":"7327","key":"1130_CR23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468(7327):1067\u201373.","journal-title":"Nature"},{"issue":"14","key":"1130_CR24","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1101\/gad.267583.115","volume":"29","author":"AA Alekseyenko","year":"2015","unstructured":"Alekseyenko AA, Walsh EM, Wang X, et al. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev. 2015;29(14):1507\u201323.","journal-title":"Genes Dev"},{"issue":"5","key":"1130_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/2159-8290.CD-15-1335","volume":"6","author":"A Stathis","year":"2016","unstructured":"Stathis A, Zucca E, Bekradda M, et al. Clinical response of carcinomas harboring the BRD4-NUT oncoprotein to the targeted bromodomain inhibitor OTX015\/MK-8628. Cancer Discov. 2016;6(5):492\u2013500.","journal-title":"Cancer Discov"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.2147\/OTT.S173056","volume":"12","author":"M Napolitano","year":"2019","unstructured":"Napolitano M, Venturelli M, Molinaro E, et al. NUT midline carcinoma of the head and neck: current perspectives. Onco Targets Ther. 2019;12:3235\u201344.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1130_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","volume":"280","author":"W Weichert","year":"2009","unstructured":"Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett. 2009;280(2):168\u201376.","journal-title":"Cancer Lett"},{"issue":"3","key":"1130_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/cancers11030304","volume":"11","author":"G Manzotti","year":"2019","unstructured":"Manzotti G, Ciarrocchi A, Sancisi V. Inhibition of BET proteins and histone deacetylase (HDACs): crossing roads in cancer therapy. Cancers (Basel). 2019;11(3):304.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1130_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/hepr.12757","volume":"47","author":"H Zhang","year":"2017","unstructured":"Zhang H, Shang YP, Chen HY, et al. Histone deacetylases function as novel potential therapeutic target for cancer. Hepatol Res. 2017;47(2):149\u201359.","journal-title":"Hepatol Res"},{"issue":"8","key":"1130_CR30","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.urolonc.2012.06.015","volume":"31","author":"G Niegish","year":"2013","unstructured":"Niegish G, Knievel J, Koch A, et al. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. Urol Oncol. 2013;31(8):1770\u20139.","journal-title":"Urol Oncol"},{"issue":"1","key":"1130_CR31","first-page":"117","volume":"29","author":"T Sakuma","year":"2006","unstructured":"Sakuma T, Uzawa K, Onda T, et al. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol. 2006;29(1):117\u201324.","journal-title":"Int J Oncol"},{"issue":"8","key":"1130_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-018-0788-2","volume":"9","author":"J Cao","year":"2018","unstructured":"Cao J, Lv W, Wang L, et al. Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d\/PI3K\/AKT\/mTOR and ERK pathways. Cell Death Dis. 2018;9(8):817.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1130_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.18632\/aging.100980","volume":"8","author":"LS Zeng","year":"2016","unstructured":"Zeng LS, Yang XZ, Wen YF, et al. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. Aging (Albany, NY). 2016;8(6):1236\u201348.","journal-title":"Aging (Albany, NY)"},{"issue":"1","key":"1130_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/ol.2016.5436","volume":"13","author":"S Li","year":"2017","unstructured":"Li S, Wang F, Qu Y, et al. HDAC2 regulates cell proliferation, cell cycle progression and cell apoptosis in esophageal squamous cell carcinoma EC9706 cells. Oncol Lett. 2017;13(1):403\u20139.","journal-title":"Oncol Lett"},{"issue":"5","key":"1130_CR35","first-page":"6552","volume":"16","author":"MY Ahn","year":"2018","unstructured":"Ahn MY. HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression. Oncol Lett. 2018;16(5):6552\u2013600.","journal-title":"Oncol Lett"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01130-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-020-01130-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01130-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:49:05Z","timestamp":1611622145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-020-01130-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s12105-020-01130-6","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"16 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}